doi: 10.1038/S41598-019-55524-W 116 O'NeilPMBirkenfeldALMcGowanBMosenzonOPedersenSDWhartonSet al
Definitions: SNRI= Serotonin-norepinephrine reuptake inhibitors
Unfortunately, despite significant advances in anti-glycemic therapies, macrovascular complications are still the most common cause of death in T2D patients [5]
Gu W, Wang H, Huang X, Kraiczy J, Singh P, Ng C, et al
There are minimal risks associated with the treatment, and side effects are rare
Yes, patients can switch between semaglutide and tirzepatide, but the transition requires medical supervision and careful dose adjustments